WallStreetZenWallStreetZen

NASDAQ: PRTK
Paratek Pharmaceuticals Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

PRTK past revenue growth

How has PRTK's revenue growth performed historically?
Company
20.24%
Industry
69.54%
Market
14.01%
PRTK's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
PRTK's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
PRTK's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

PRTK earnings and revenue history

Current Revenue
$166.6M
Current Earnings
-$65.8M
Current Profit Margin
-39.5%

PRTK Return on Equity

Insufficient data to display

Be the first to know when PRTK announces earnings.

PRTK Return on Assets

Current Company
-40.8%
Current Industry
0.9%
PRTK is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

PRTK Return on Capital Employed

Current Company
-40.28%
Current Industry
14.1%
PRTK has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PRTK vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
PRTK$166.64M-$47.17M-$65.80M+67.58%N/A
ONCY$0.00-$17.66M-$18.01MN/AN/A
CLLS$25.45M-$63.94M-$104.30M-4.17%N/A
CVM$0.00-$30.55M-$35.39M-100.00%N/A
ARAV$9.54M-$112.34M-$113.22M-24.93%N/A
View Top Biotech Stocks

PRTK earnings dates

Next earnings date
Aug 1, 2023

Paratek Pharmaceuticals Earnings & Revenue FAQ

What were PRTK's earnings last quarter?

On Invalid Date, Paratek Pharmaceuticals (NASDAQ: PRTK) reported Q1 2023 earnings per share (EPS) of -$0.35, up 0% year over year. Total Paratek Pharmaceuticals earnings for the quarter were -$20.14 million. In the same quarter last year, Paratek Pharmaceuticals's earnings per share (EPS) was -$0.35.

If you're new to stock investing, here's how to buy Paratek Pharmaceuticals stock.

What was PRTK's earnings growth in the past year?

As of Q2 2023, Paratek Pharmaceuticals's earnings has grown year over year. Paratek Pharmaceuticals's earnings in the past year totalled -$65.80 million.

What is PRTK's earnings date?

Paratek Pharmaceuticals's earnings date is Invalid Date. Add PRTK to your watchlist to be reminded of PRTK's next earnings announcement.

What was PRTK's revenue last quarter?

On Invalid Date, Paratek Pharmaceuticals (NASDAQ: PRTK) reported Q1 2023 revenue of $31.24 million up 25.64% year over year. In the same quarter last year, Paratek Pharmaceuticals's revenue was $24.86 million.

What was PRTK's revenue growth in the past year?

As of Q2 2023, Paratek Pharmaceuticals's revenue has grown 20.24% year over year. This is 49.3 percentage points lower than the US Biotechnology industry revenue growth rate of 69.54%. Paratek Pharmaceuticals's revenue in the past year totalled $166.64 million.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.